My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Biodesix, Inc. - Common Stock (NQ:BDSX)

5.950 -0.280 (-4.49%)

Streaming Delayed Price Updated: 2:03 PM EST, Jan 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Biodesix, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Biodesix to Report Second Quarter 2024 Financial Results on August 7, 2024

July 24, 2024

From Biodesix, Inc.

Via Business Wire

Biodesix Named to Inc. Magazine’s 2024 “Best Workplaces”

June 18, 2024

From Biodesix, Inc.

Via Business Wire

Biodesix to Participate in Two Investor Conferences in June

May 28, 2024

From Biodesix, Inc.

Via Business Wire

Biodesix Reports 65% Growth In Lung Diagnostic Test Volume In Q4 ↗

March 02, 2024

Biodesix Inc. reported strong Q4 performance, with significant revenue growth.

Via Talk Markets

Biodesix: Q4 Earnings Insights ↗

March 01, 2024

Via Benzinga

Biodesix to Present New Data on the Nodify XL2® Test at ATS 2024 Annual Meeting

May 21, 2024

From Biodesix, Inc.

Via Business Wire

BDSX Stock Earnings: Biodesix Beats EPS, Beats Revenue for Q1 2024 ↗

May 08, 2024

BDSX stock results show that Biodesix beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule Management

May 08, 2024

From Biodesix, Inc.

Via Business Wire

Biodesix's Earnings Outlook ↗

February 29, 2024

Via Benzinga

Recap: Biodesix Q3 Earnings ↗

November 07, 2023

Via Benzinga

Biodesix to Participate in the 2024 RBCCM Global Healthcare Conference

May 07, 2024

From Biodesix, Inc.

Via Business Wire

Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024

April 24, 2024

From Biodesix, Inc.

Via Business Wire

Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting

April 09, 2024

From Biodesix, Inc.

Via Business Wire

S&P 500 Gains Over 1%; GCT Semiconductor Shares Spike Higher ↗

April 05, 2024

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Friday. The Dow traded up 0.89% to 38,941.18 while the NASDAQ rose 1.26% to 16,251.98. The...

Via Benzinga

Topics Stocks

Why Byrna Technologies Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

April 05, 2024

Shares of Byrna Technologies Inc. (NASDAQ: BYRN) rose sharply during Friday’s session after the company reported better-than-expected first-quarter revenue, and announced a CFO transition.

Via Benzinga

Gold Surges Over 1%; Biodesix Shares Plummet ↗

April 05, 2024

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 200 points on Friday. The Dow traded up 1.01% to 38,987.23 while the NASDAQ rose 1.50% to 16,289.37. The...

Via Benzinga

Topics Stocks

Dow Jumps Over 100 Points; US Economy Adds 303,000 Jobs In March ↗

April 05, 2024

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 100 points on Friday. Following the market opening Friday, the Dow traded up 0.30% to 38,713.29 while the NASDAQ rose 0.35%...

Via Benzinga

Topics Economy Stocks

Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement

April 05, 2024

From Biodesix, Inc.

Via Business Wire

Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center

March 25, 2024

From Biodesix, Inc.

Via Business Wire

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

March 01, 2024

Via Benzinga

Earnings Scheduled For March 1, 2024 ↗

March 01, 2024

Companies Reporting Before The Bell • McEwen Mining (NYSE:MUX) is estimated to report quarterly loss at $0.28 per share on revenue of $71.72 million.

Via Benzinga

Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights

March 01, 2024

From Biodesix, Inc.

Via Business Wire

Biodesix to Participate in the TD Cowen 44th Annual Health Care Conference

February 26, 2024

From Biodesix, Inc.

Via Business Wire

Biodesix to Report Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024

February 16, 2024

From Biodesix, Inc.

Via Business Wire

3 Penny Stocks to Turn $999 Into $1 Million: January 2024 ↗

January 26, 2024

With our strengthening economy, you need to invest in penny stocks that will deliver high future returns, these three are your best bets.

Via InvestorPlace

Topics Economy

Biodesix Enhances Access to Nodify Lung® Testing with Launch of New Blood Draw Method

November 14, 2023

From Biodesix, Inc.

Via Business Wire

Biodesix to Participate in Two Upcoming Investor Conferences in November

November 09, 2023

From Biodesix, Inc.

Via Business Wire

Biodesix Announces Third Quarter 2023 Results and Highlights

November 07, 2023

From Biodesix, Inc.

Via Business Wire

Biodesix to Report Third Quarter 2023 Financial Results on November 7, 2023

October 24, 2023

From Biodesix, Inc.

Via Business Wire

Biodesix to Present New Data on Nodify Lung® Testing at CHEST 2023 Annual Meeting

October 03, 2023

From Biodesix, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.